Dalia Dawoud

2.7k total citations
93 papers, 1.2k citations indexed

About

Dalia Dawoud is a scholar working on Economics and Econometrics, General Health Professions and Geriatrics and Gerontology. According to data from OpenAlex, Dalia Dawoud has authored 93 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Economics and Econometrics, 18 papers in General Health Professions and 9 papers in Geriatrics and Gerontology. Recurrent topics in Dalia Dawoud's work include Health Systems, Economic Evaluations, Quality of Life (46 papers), Pharmaceutical Economics and Policy (20 papers) and Healthcare cost, quality, practices (10 papers). Dalia Dawoud is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (46 papers), Pharmaceutical Economics and Policy (20 papers) and Healthcare cost, quality, practices (10 papers). Dalia Dawoud collaborates with scholars based in United Kingdom, Egypt and United States. Dalia Dawoud's co-authors include Nirmeen A. Sabry, Samar Farid, Zaheer‐Ud‐Din Babar, Dyfrig Hughes, Páll Jónsson, Jamie Elvidge, Rabia Hussain, Jacoline C. Bouvy, Jill Maben and David Wonderling and has published in prestigious journals such as The Lancet Neurology, BMJ and Journal of Clinical Epidemiology.

In The Last Decade

Dalia Dawoud

87 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dalia Dawoud United Kingdom 21 294 218 211 123 120 93 1.2k
Imran Masood Pakistan 19 168 0.6× 262 1.2× 115 0.5× 140 1.1× 103 0.9× 81 1.2k
Piotr Merks Poland 15 134 0.5× 254 1.2× 140 0.7× 73 0.6× 122 1.0× 93 790
Jean‐François Bussières Canada 23 252 0.9× 511 2.3× 175 0.8× 61 0.5× 196 1.6× 295 1.9k
Cassyano Januário Correr Brazil 25 271 0.9× 645 3.0× 297 1.4× 69 0.6× 119 1.0× 101 1.8k
Haitham Tuffaha Australia 18 235 0.8× 152 0.7× 165 0.8× 31 0.3× 120 1.0× 78 1.2k
Ahmed Al‐Jedai Saudi Arabia 20 120 0.4× 271 1.2× 90 0.4× 78 0.6× 111 0.9× 106 950
Mercè Comas Spain 22 217 0.7× 33 0.2× 165 0.8× 125 1.0× 86 0.7× 73 1.5k
Janice L. Kwan Canada 17 170 0.6× 365 1.7× 419 2.0× 31 0.3× 193 1.6× 39 1.6k
Francesc Cots Spain 22 461 1.6× 26 0.1× 510 2.4× 91 0.7× 119 1.0× 70 1.6k
Augusto Afonso Guerra Brazil 27 590 2.0× 205 0.9× 572 2.7× 33 0.3× 244 2.0× 153 2.2k

Countries citing papers authored by Dalia Dawoud

Since Specialization
Citations

This map shows the geographic impact of Dalia Dawoud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dalia Dawoud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dalia Dawoud more than expected).

Fields of papers citing papers by Dalia Dawoud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dalia Dawoud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dalia Dawoud. The network helps show where Dalia Dawoud may publish in the future.

Co-authorship network of co-authors of Dalia Dawoud

This figure shows the co-authorship network connecting the top 25 collaborators of Dalia Dawoud. A scholar is included among the top collaborators of Dalia Dawoud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dalia Dawoud. Dalia Dawoud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gsteiger, Sandro, Keith R. Abrams, Dalia Dawoud, et al.. (2025). Evaluating amyloid-beta as a surrogate endpoint in trials of anti-amyloid-beta drugs in Alzheimer’s disease: a Bayesian meta-analysis. Journal of Comparative Effectiveness Research. 15(1). e250095–e250095.
2.
Sparks, Matthew A., Anna Burgner, Dalia Dawoud, et al.. (2025). Current State and Future Direction of Vascular Access Training in the United States. Clinical Journal of the American Society of Nephrology. 20(4). 539–546. 1 indexed citations
3.
4.
Gomes, Manuel, Alex Turner, Cormac Sammon, et al.. (2024). Acceptability of Using Real-World Data to Estimate Relative Treatment Effects in Health Technology Assessments: Barriers and Future Steps. Value in Health. 27(5). 623–632. 3 indexed citations
5.
Oja, Marek, Kerli Mooses, Sulev Reisberg, et al.. (2024). Markov modeling for cost-effectiveness using federated health data network. Journal of the American Medical Informatics Association. 31(5). 1093–1101. 1 indexed citations
6.
Elvidge, Jamie, Saskia Knies, Bertalan Németh, et al.. (2023). Health technology assessment of tests for SARS-CoV-2 and treatments for COVID-19: A proposed approach and best-practice recommendations. International Journal of Technology Assessment in Health Care. 39(1). e24–e24. 4 indexed citations
7.
Manyara, Anthony Muchai, Philippa Davies, Derek Stewart, et al.. (2023). Definitions, acceptability, limitations, and guidance in the use and reporting of surrogate end points in trials: a scoping review. Journal of Clinical Epidemiology. 160. 83–99. 12 indexed citations
8.
Németh, Bertalan, Maria Kamusheva, Antal Zemplényi, et al.. (2023). Guidance on using real-world evidence from Western Europe in Central and Eastern European health policy decision making. Journal of Comparative Effectiveness Research. 12(4). e220157–e220157. 2 indexed citations
9.
Vreman, Rick A., Anna Zawada, Magdalena Zielińska, et al.. (2023). Synergy between health technology assessments and clinical guidelines for multiple sclerosis. Clinical and Translational Science. 16(5). 835–849. 6 indexed citations
10.
Elvidge, Jamie, et al.. (2023). Diagnostics and treatments of COVID-19: two-year update to a living systematic review of economic evaluations. Frontiers in Pharmacology. 14. 1291164–1291164. 1 indexed citations
11.
Manyara, Anthony Muchai, Philippa Davies, Derek Stewart, et al.. (2022). Protocol for the development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: SPIRIT-SURROGATE and CONSORT-SURROGATE. BMJ Open. 12(10). e064304–e064304. 12 indexed citations
12.
Dawoud, Dalia, Pedro Amariles, John Jackson, et al.. (2020). Pharmacy Practice Research. Pharmacy Education. 20(3). 91–132. 1 indexed citations
13.
Dawoud, Dalia, et al.. (2020). PRO89 The Use of EQ-5D in NICE Highly Specialised Technologies Evaluations: A Review of Published Guidance. Value in Health. 23. S705–S705. 1 indexed citations
14.
Ibrahim, Osama Mohamed, et al.. (2019). KNOWLEDGE AND PERCEPTIONS OF VITAMIN D DEFICIENCY AMONG THE UNITED ARAB EMIRATES POPULATION. Asian Journal of Pharmaceutical and Clinical Research. 183–186. 5 indexed citations
15.
Glen, Jessica, Dalia Dawoud, Sofia Dias, et al.. (2019). Venous Thromboembolism Prophylaxis Strategies for People Undergoing Elective Total Hip Replacement: A Systematic Review and Network Meta-Analysis. Value in Health. 22(8). 953–969. 7 indexed citations
16.
Hasan, Syed Shahzad, et al.. (2018). Pharmaceutical Policy Reforms to Regulate Drug Prices in the Asia Pacific Region: The Case of Australia, China, India, Malaysia, New Zealand, and South Korea. Value in Health Regional Issues. 18. 18–23. 21 indexed citations
17.
Dawoud, Dalia, et al.. (2018). PMS23 - OPTIMIZING TREATMENT FOR RHEUMATOID ARTHRITIS IN THE KINGDOM OF SAUDI ARABIA (OPTRA). Value in Health. 21. S291–S291. 1 indexed citations
18.
Dawoud, Dalia, Elisabetta Fenu, Bernard Higgins, David Wonderling, & Stephanie A. Amiel. (2017). Basal Insulin Regimens for Adults with Type 1 Diabetes Mellitus: A Cost-Utility Analysis. Value in Health. 20(10). 1279–1287. 6 indexed citations
19.
Dawoud, Dalia, et al.. (2017). Basal Insulin Regimens for Adults with Type 1 Diabetes Mellitus: A Systematic Review and Network Meta-Analysis. Value in Health. 21(2). 176–184. 9 indexed citations
20.
Sabry, Nirmeen A., Samar Farid, & Dalia Dawoud. (2016). Drug-related problems in cardiac children.. PubMed. 68(2). 89–95. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Imran Masood Breakdown of academic impact, for papers by Piotr Merks Breakdown of academic impact, for papers by Jean‐François Bussières Breakdown of academic impact, for papers by Cassyano Januário Correr Breakdown of academic impact, for papers by Haitham Tuffaha Breakdown of academic impact, for papers by Ahmed Al‐Jedai Breakdown of academic impact, for papers by Mercè Comas Breakdown of academic impact, for papers by Janice L. Kwan Breakdown of academic impact, for papers by Francesc Cots Breakdown of academic impact, for papers by Augusto Afonso Guerra
Rankless by CCL
2026